Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis - PubMed (original) (raw)

Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis

E M Tan. J Clin Invest. 2001 Nov.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Figure 1

Tumor nodule from a patient with HCC examined by immunohistochemistry (a), showing expression of p62 protein in cytoplasm of cancer cells but no detectable p62 in hepatic or other cells in adjacent noncancer areas. One of two cholangiocarcinoma patients showed expression of p62 in cytoplasm of malignant bile duct cells (b).

Similar articles

Cited by

References

    1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 1989;44:93–151. - PubMed
    1. Notkins A, Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest. 2001;108:1247–1252. - PMC - PubMed
    1. Rapoport B, McLachlan SM. Thyroid autoimmunity. J Clin Invest. 2001;108:1253–1259. - PMC - PubMed
    1. Papadopoulos GK, Wijmenga C, Koning F. Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life. J Clin Invest. 2001;108:1261–1266. - PMC - PubMed
    1. Szabo A, et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethal. Cell. 1991;67:325–333. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources